3 Phosphatic Fertilisers Maker, Hospital Operator and Aluminium and Copper Producer Stocks With a Strong Future Roadmap: Paradeep Phosphates, Jupiter Life Line Hospitals and Hindalco Industries

Phosphate, hospital and aluminium stocks give investors a way to track businesses that sit close to everyday demand in India. Paradeep Phosphates, Jupiter Life Line Hospitals and Hindalco Industries cover a phosphatic fertilisers maker, a hospital operator and an aluminium and copper producer.

This list covers three phosphate, hospital and aluminium stocks with complete current figures: Paradeep Phosphates, Jupiter Life Line Hospitals and Hindalco Industries. Every figure comes from the latest reported financials and the 11 November 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

What Are Phosphate, Hospital and Aluminium Stocks?

Phosphate, hospital and aluminium stocks are listed companies that make DAP and complex phosphatic fertilisers for farmers, run hospitals with specialist care units, and produce aluminium, copper and specialty metal products. Their earnings depend on farm demand, patient volumes and metal prices.

Phosphate, Hospital and Aluminium Stocks at a Glance

On valuation, Paradeep Phosphates and Jupiter Life Line Hospitals trade at a P/E below the industry P/E, while Hindalco Industries trades above it, which reflects the growth the market already expects. Readers comparing phosphate, hospital and aluminium stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.

Why Do Phosphate, Hospital and Aluminium Stocks Have a Strong Roadmap in India?

Phosphate, hospital and aluminium stocks have a strong roadmap in India because steady farm input needs, rising need for quality hospital care and wider use of aluminium and copper in power and vehicles keep widening the market for these companies.

• Phosphatic fertilisers. Farms need reliable crop nutrients.
• Hospitals. Families seek quality specialist care.
• Aluminium and copper. Power and vehicles use more metal.

Why Paradeep Phosphates Features Among These Phosphate, Hospital and Aluminium Stocks

Among the phosphate, hospital and aluminium stocks on this list, Paradeep Phosphates makes phosphatic fertilisers such as DAP and NPK grades from its plant in Odisha, serving farmers across eastern and central India.

The company has a return on equity of 14.7%, a debt to equity ratio of 1.02 and a market capitalisation of Rs 15,007 crore. The stock trades at a P/E of 14.0, below the industry P/E of 21.2.

Revenue rose from Rs 7,898 crore in FY22 to Rs 21,973 crore in FY26, a compound annual growth rate of 29.1%. Net profit grew from Rs 398 crore in FY22 to Rs 996 crore in FY26, which works out to a compound annual growth rate of 25.8%. In the June 2026 quarter, revenue grew 35.4% year on year to Rs 6,146 crore, while net profit rose 23.9% to Rs 393 crore.

Roadmap: The company has expanded capacity and is working to increase volumes of complex fertilisers across its network. Its coastal location supports imports of raw material, and expansion plans support future volumes.

What to watch: Watch raw material prices, subsidy policy and the volume of new capacity coming on stream.

Why Jupiter Life Line Hospitals Features Among These Phosphate, Hospital and Aluminium Stocks

Among the crop nutrient, care centre and metal shares on this list, Jupiter Life Line Hospitals runs multi-speciality hospitals in Pune, Thane and Indore, with strong services in maternity, child care, critical care and advanced surgery.

Revenue rose from Rs 737 crore in FY22 to Rs 1,542 crore in FY26, a compound annual growth rate of 20.3%. Net profit grew from Rs 51.1 crore in FY22 to Rs 194 crore in FY26, which works out to a compound annual growth rate of 39.6%.

The company has a return on equity of 11.4%, a debt to equity ratio of 0.41 and a market capitalisation of Rs 8,007 crore. The stock trades at a P/E of 42.6, below the industry P/E of 58.4.

Roadmap: The company is adding beds and expanding to new locations while growing specialist services. Rising demand for quality private care in its cities supports occupancy.

What to watch: Follow bed additions, occupancy levels and revenue per occupied bed.

Why Hindalco Industries Features Among These Phosphate, Hospital and Aluminium Stocks

Among the three companies on this list, Hindalco Industries is a metals leader with aluminium, copper and speciality alumina businesses, and it owns Novelis, one of the world's largest aluminium rolling and recycling companies.

In the June 2026 quarter, revenue grew 32.5% year on year to Rs 85,882 crore, while net profit rose 75.1% to Rs 7,013 crore. Revenue rose from Rs 196,195 crore in FY22 to Rs 277,833 crore in FY26, a compound annual growth rate of 9.1%.

Net profit grew from Rs 10,097 crore in FY23 to Rs 13,391 crore in FY26, which works out to a compound annual growth rate of 9.9%. The company has a return on equity of 12.8%, a debt to equity ratio of 0.73 and a market capitalisation of Rs 202,250 crore. The stock trades at a P/E of 12.3, above the industry P/E of 11.6.

Roadmap: The company is investing in aluminium downstream products, copper and battery foil, and Novelis is expanding capacity for beverage cans and automotive aluminium. A mix of upstream and downstream operations spreads exposure across the aluminium chain.

What to watch: Monitor aluminium and copper price trends and the progress of its major capex projects.

Paradeep Phosphates vs Jupiter Life Line Hospitals vs Hindalco Industries on Key Financials

The table below sets the three phosphate, hospital and aluminium stocks side by side on revenue, profit and margin, using reported figures.

Paradeep Phosphates posts the highest return on equity in this group at 14.7%. Hindalco Industries has the largest FY26 revenue at Rs 277,833 crore, and Paradeep Phosphates shows the fastest revenue growth with a 29.1% compound annual rate. A useful habit with phosphate, hospital and aluminium stocks is to check each new quarterly result against the capacity plans the company described earlier.

Key Risks to Check Before Investing in Phosphate, Hospital and Aluminium Stocks

Every theme carries risks that deserve a check before any decision. For these phosphate, hospital and aluminium stocks, the main points are: Long-term crop nutrient, care centre and metal shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.

• Season and monsoon. Crop protection sales follow rain and pest cycles.
• Capacity ramp up. New hospitals take time to fill beds and reach full returns.
• Commodity prices. Selling prices follow global and domestic markets.

Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.

Use the Univest Stock Screener to filter phosphate, hospital and aluminium stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.

Final Thoughts on Phosphate, Hospital and Aluminium Stocks

Phosphate, hospital and aluminium stocks work best when investors track growth, valuation and return on equity side by side. Paradeep Phosphates, Jupiter Life Line Hospitals and Hindalco Industries each have a clear plan to grow. Based on the 11 November 2026 close, Paradeep Phosphates trades at Rs 143.91, Jupiter Life Line Hospitals at Rs 286.5 and Hindalco Industries at Rs 962.3.

Download the Univest iOS App or Univest Android App to track phosphate, hospital and aluminium stocks, set price alerts and get research-backed stock ideas.

What are phosphate, hospital and aluminium stocks?

Ans. Phosphate, hospital and aluminium stocks are listed companies that make DAP and complex phosphatic fertilisers for farmers, run hospitals with specialist care units, and produce aluminium, copper and specialty metal products. Their earnings depend on farm demand, patient volumes and metal prices. This list looks at three of them, Paradeep Phosphates, Jupiter Life Line Hospitals and Hindalco Industries, using reported FY22 to FY26 financials and the 11 November 2026 closing prices.

Which phosphate, hospital and aluminium stocks are covered in this list?

Ans. This list covers Paradeep Phosphates, Jupiter Life Line Hospitals and Hindalco Industries. Based on the 11 November 2026 close, Paradeep Phosphates traded at Rs 143.91, Jupiter Life Line Hospitals at Rs 286.5 and Hindalco Industries at Rs 962.3. Their return on equity ranges from 11.4% to 14.7%, and their revenue compound annual growth from FY22 to FY26 ranges from 9.1% to 29.1%.

Why do phosphate, hospital and aluminium stocks have a strong future roadmap in India?

Ans. Phosphate, hospital and aluminium stocks have a strong roadmap in India because steady farm input needs, rising need for quality hospital care and wider use of aluminium and copper in power and vehicles keep widening the market for these companies. The main drivers are as follows. Phosphatic fertilisers. Farms need reliable crop nutrients. Hospitals. Families seek quality specialist care. Aluminium and copper. Power and vehicles use more metal. Together these factors give the companies on this list a visible path for growth over the coming years.

How has Paradeep Phosphates performed financially?

Ans. Revenue rose from Rs 7,898 crore in FY22 to Rs 21,973 crore in FY26, a compound annual growth rate of 29.1%. Net profit grew from Rs 398 crore in FY22 to Rs 996 crore in FY26, which works out to a compound annual growth rate of 25.8%. In the June 2026 quarter, revenue grew 35.4% year on year to Rs 6,146 crore, while net profit rose 23.9% to Rs 393 crore. The company has a return on equity of 14.7%, a debt to equity ratio of 1.02 and a market capitalisation of Rs 15,007 crore. The stock trades at a P/E of 14.0, below the industry P/E of 21.2. Looking ahead, the company has expanded capacity and is working to increase volumes of complex fertilisers across its network. Its coastal location supports imports of raw material, and expansion plans support future volumes.

How has Jupiter Life Line Hospitals performed financially?

Ans. Revenue rose from Rs 737 crore in FY22 to Rs 1,542 crore in FY26, a compound annual growth rate of 20.3%. Net profit grew from Rs 51.1 crore in FY22 to Rs 194 crore in FY26, which works out to a compound annual growth rate of 39.6%. The company has a return on equity of 11.4%, a debt to equity ratio of 0.41 and a market capitalisation of Rs 8,007 crore. The stock trades at a P/E of 42.6, below the industry P/E of 58.4. Looking ahead, the company is adding beds and expanding to new locations while growing specialist services. Rising demand for quality private care in its cities supports occupancy.

How has Hindalco Industries performed financially?

Ans. Revenue rose from Rs 196,195 crore in FY22 to Rs 277,833 crore in FY26, a compound annual growth rate of 9.1%. Net profit grew from Rs 10,097 crore in FY23 to Rs 13,391 crore in FY26, which works out to a compound annual growth rate of 9.9%. In the June 2026 quarter, revenue grew 32.5% year on year to Rs 85,882 crore, while net profit rose 75.1% to Rs 7,013 crore. The company has a return on equity of 12.8%, a debt to equity ratio of 0.73 and a market capitalisation of Rs 202,250 crore. The stock trades at a P/E of 12.3, above the industry P/E of 11.6. Looking ahead, the company is investing in aluminium downstream products, copper and battery foil, and Novelis is expanding capacity for beverage cans and automotive aluminium. A mix of upstream and downstream operations spreads exposure across the aluminium chain.

What risks should investors check before buying phosphate, hospital and aluminium stocks?

Ans. Investors should check a few risks before buying phosphate, hospital and aluminium stocks. Season and monsoon. Crop protection sales follow rain and pest cycles. Capacity ramp up. New hospitals take time to fill beds and reach full returns. Commodity prices. Selling prices follow global and domestic markets. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.

Is this list of phosphate, hospital and aluminium stocks investment advice?

Ans. No. This article is educational and uses publicly available data as of the 11 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.